Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

in response to

Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

noretreat

posted on Aug 06, 2019 11:32AM

I am not sure 100% but it looks like the CEO of Newsoara Biophama, Benny Li could be related to the Li family of Hepalink Shenzhan, Could that last name just be coincidence or is there more to the story of their investment in Zenith Epigenetics,....

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply